Muvalaplin and Olpasiran Show Promise in Lowering Lp(a) ...Middle East

Medscape - News
Oral muvalaplin lowered lipoprotein(a) in a phase 1 study, and injectable olpasiran did so in an extension of a phase 2 study, both with no adverse safety signals, researchers report. Medscape Medical News

Hence then, the article about muvalaplin and olpasiran show promise in lowering lp a was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Muvalaplin and Olpasiran Show Promise in Lowering Lp(a) )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News